• Monday - Thursday: 9.00 am - 6.00 pm

Our Investigators

Meet one of our Principal Investigators.

Mark Hinds – BIO 2021
BScApp(Optom) (Queensland University of Technology) 
GradCertOcTher (Queensland University of Technology)
BScApp(HMS) (University of Queensland) 
P/G BscHons – Exercise Physiology (University of Queensland) 
FBCLA (Manchester)

FIAOMC
CASA CO (Melbourne)

Mark has a full scope private practice in Teneriffe, Brisbane QLD with a clinical focus on specialty contact lenses for the complex cornea established in 2001.  He is one of the providers for rigid gas permeable and scleral contact lenses for those patients in Queensland on the public corneal graft list. He is referred patients for visual rehabilitation through specialty contact lenses for those with visual disability from corneal irregularity and ocular surface disease.

He is a QUT graduate (1999) and has completed the post-graduate certificate in ocular therapeutics (2004). Additionally, he has an undergraduate degree in Applied Science (1993) and postgraduate Bachelor of Science research honours in exercise physiology (1994) from the University of Queensland. 

He is a fellow of the British Contact Lens Association and the International Academy of Orthokeratology and Myopia Control. Mark has been involved with QUT School of Optometry post graduate Master of Optometry program in the specialty contact lens clinics since 2004 and lectures to the 4th year students in their advance contact lens program. He has received the QUT vice chancellor’s award for excellence for teaching in 2010 and 2013. 

Ongoing, he presents regularly for contact lens industry and in his own right at national and international conferences, consults to industry as a KOL, and is a referee for Clinical and Experimental Optometry.  

His pursuit of clinical trials seeds from his post graduate exercise physiology research and publication as the principal investigator on creatine supplementation in elite cyclists back in 1995. Since 2003 he has been and is currently involved in optometry based clinical pharma, contact lens and product development trials.  In 2018, due the expansion in practice with onsite clinical trials, a purpose-built practice was completed in Teneriffe (Brisbane) to accommodate larger numbers of participants with a flexible working floor plan.  This was saw the inception of Ophthalmic Trials Australia.

Since 2018 he has been involved in the testing of and application of 3D ocular surface mapping for designing and manufacturing custom 3D large diameter contact lenses particularly for irregular ocular surfaces.  This modelling has been specifically applied successfully to >250 eyes with hyper-oxygen permeable mini-scleral contact lenses. 

From 2018 to current he oversees the Australian Professional Services and distribution for SynergEyes USA specialty hybrid contact lenses. 

He works in a consultant capacity with Bausch & Lomb, Alcon, Johnson and Johnson Vision Care (Australia and New Zealand advisory board member since 2013) and Gelflex / ACL.   

Current Registrations:

  1. Optometry Australia
  2. Australian Health Practitioner Regulation Agency (AHPRA) 
  3. Cornea and Contact Lens Society of Australia
  4. British Contact Lens Association
  5. International Academy of Orthokeratology and Myopia Control
  6. Civil Aviation Safety Authority Credentialed Optometrist 
  7. GPC NIDA Clinical Trials Network

Current / recent clinical trial working relationships:

  1. Novotech CRO. Sponsor – Nevakar Inc (USA).
  2. Royal Brisbane and Women’s Hospital Department of Endocrinology and Diabetes (Multisite coordinated by NHMRC Clinical Trials Centre).  Sponsor – University of Sydney (Eli Lilly and Company USA). 
  3. University of Sunshine Coast. 
  4. Bausch and Lomb.
  5. Novo Nordisk Pharmaceuticals.
  6. Azura Ophthalmics.
  7. Syneos Health.